Prolonged survival of rat liver allograft with adenoviral gene transfection of human immunodeficiency virus type 1 nef

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 805-813

  Fujino, Masayuki ^a   Adachi, Kensuke ^a   Kawasaki, Mikiko ^a   Kitazawa, Yusuke ^a   Funeshima, Naoko ^a   Okuyama, Torayuki ^a   Kimura, Hiromitsu ^a   Li, Xiao Kang ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; REGULATOR PROTEIN;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GRAFT SURVIVAL; HISTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; STATISTICAL SIGNIFICANCE; UPREGULATION; VIRUS RECOMBINANT; WESTERN BLOTTING;

EID: 0042062513     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50149     Document Type: Article

References (46)

1. Giannoukakis N, Thomson A, Robbins P. Gene therapy in transplantation. Gene Ther 1999;6:1499-1511.
2. Wood KJ, Prior TG. Gene therapy in transplantation. Curr Opin Mol Ther 2001;3:390-398.
3. Fujino M, Li XK, Funeshima N, Okuyama T, Enosawa S, Amano T, et al. Exogenous gene expression by Cre/LoxP-mediated switching system containing adenovirus vector in mouse. Organ Biol 1998;5:45-52.
4. Adachi K, Li XK, Guo L, Fujino M, Funeshima N, Kimura H, et al. High efficacy of gene transfer and expression using adenovirus vector in the rat liver transplantation model. Transplant Proc 2000;32:2514-2515.
5. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994;1:433-442.
6. Jooss K, Ertl HC, Wilson JM. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J Virol 1998;72:2945-2954.
7. Ploegh HL. Viral strategies of immune evasion. Science 1998; 280:248-253.
8. Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A 1991;88:1172-1176.
9. Zuo Z, Wang C, Carpenter D, Okada Y, Nicolaidou E, Toyoda M, et al. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Transplantation 2001;71:686-691.
10. Efrat S, Fejer G, Brownlee M, Horwitz MS. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci U S A 1995;92:6947-6951.
11. Adachi K, Li X, Kimura H, Amemiya H, Suzuki S. Prolonged survival of rat liver allografts with CrmA gene transfer. Transplant Proc 2001;33:605.
12. Michael NL, Chang G, d'Arcy LA, Ehrenberg PK, Mariani R, Busch MP, et al. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol 1995;69:4228-4236.
13. Kestler HW 3rd, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65: 651-662.
14. Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 1991;350: 508-511.
15. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996;2: 338-342.
16. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. HIV-1 Nef inhibits ASK1-dependent death signaling providing a potential mechanism for protecting the infected host cell. Nature 2001;410:834-838.
17. Xu XN, Laffert B, Screaton GR, Kraft M, Wolf D, Kolanus W, et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 1999;189:1489-1496.
18. Hodge S, Novembre FJ, Whetter L, Gelbard HA, Dewhurst S. Induction of fas ligand expression by an acutely lethal simian immunodeficiency virus, SIVsmmPBj14. Virology 1998;252: 354-363.
19. Xu XN, Screaton GR, Gotch FM, Dong T, Tan R, Almond N, et al. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med 1997; 186:7-16.
20. Luria S, Chambers I, Berg P. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci U S A 1991;88:5326-5330.
21. Baur AS, Sawai ET, Dazin P, Fantl WJ, Cheng-Mayer C, Peterlin BM. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994;1: 373-384.
22. Collette Y, Chang HL, Cerdan C, Chambost H, Algarte M, Mawas C, et al. Specific Th1 cytokine downregulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. J Immunol 1996;156:360-370.
23. Iafrate AJ, Bronson S, Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. Embo J 1997;16:673-684.
24. Peter F. HIV nef: The mother of all evil? Immunity 1998;9:433-437.
25. Kita Y, Li XK, Ohba M, Funeshima N, Enosawa S, Tamura A, et al. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. Transplantation 1999;68:758-766.
26. Li XK, Fujino M, Adachi K, Guo L, Kawasaki M, Funeshima N, et al. Prolonged survival of rat liver allografts with Fas ligand and/or CrmA gene transfer. Ishoku 2001;36:304-315.
27. Li XK, Okuyama T, Tamura A, Enosawa S, Kaneda Y, Takahara S, et al. Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. Transplantation 1998;66:1416-1423.
28. Fukushima M, Ikenaka K, Shirasaka T, Fujii S. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells. Gann 1979; 70:47-53.
29. Kawano Y, Tanaka Y, Misawa N, Tanaka R, Kira JI, Kimura T, et al. Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: Requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo. J Virol 1997;71:8456-8466.
30. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci U S A 1996;93:1320-1324.
31. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995;23:3816-3821.
32. Li XK, Tamura A, Fujino M, Guo L, Kakefuda T, Funeshima N, et al. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Clin Exp Immunol 2001;123: 331-339.
33. Fujino M, Li XK, Kitazawa Y, Funeshima N, Guo L, Okuyama T, et al. Selective repopulation of mice liver after Fas-resistant hepatocyte transplantation. Cell Transplant 2001;10:353-361.
34. Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28:47-50.
35. Miyazaki J, Takaki S, Araki K, Tashiro F, Tominaga A, Takatsu K, et al. Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5. Gene 1989;79:269-277.
36. Latinis KM, Carr LL, Peterson EJ, Norian LA, Eliason SL, Koretzky GA. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J Immunol 1997;158:4602-4611.
37. Fujino M, Li XK, Okuyama T, Funeshima N, Tamura A, Enosawa S, et al. On/off switching Fas-ligand gene expression in liver by Cre/Loxp adenovirus vector system. Transplant Proc 1999; 31:753-754.
38. Okuyama T, Li XK, Funeshima N, Fujino M, Sasaki K, Kita Y, et al. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors. J Gastroenterol Hepatol 1998;13:S113-118.
39. Kosuga M, Takahashi S, Sasaki K, Li XK, Fujino M, Hamada H, et al. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: Involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression. Mol Ther 2000;1:406-413.
40. Namii Y, Hayashi S, Yokoyama I, Kobayashi T, Yasutomi M, Nagasaka T, et al. Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival. Transplant Proc 1997;29:1738-1739.
41. Purgus R, Tamalet C, Poignard P, Spire B, George F, Robert A, et al. Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient. Transplantation 1998;66:1384-1386.
42. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
43. De SK, Venkateshan CN, Seth P, Gajdusek DC, Gibbs CJ. Adenovirus-mediated human immunodeficiency virus-1 Nef expression in human monocytes/macrophages and effect of Nef on downmodulation of Fcγ receptors and expression of monokines. Blood 1998;91:2108-2117.
44. Cramer LA, Frelinger JA. Dendritic cells transduced with HIV Nef express normal levels of HLA-A and HLA-B class I molecules. J Acquir Immune Defic Syndr 2001;27:417-425.
45. Andrieu M, Chassin D, Desoutter JF, Bouchaert I, Baillet M, Hanau D, et al. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. AIDS Res Hum Retroviruses 2001;17:1365-1370.
46. Swenson KM, Ke B, Wang T, Markowitz JS, Maggard MA, Spear GS, et al. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 1998;65:155-160.